{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:26:14Z","timestamp":1760783174472},"reference-count":85,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.mehy.2009.06.031","type":"journal-article","created":{"date-parts":[[2009,7,25]],"date-time":"2009-07-25T17:08:37Z","timestamp":1248541717000},"page":"942-947","source":"Crossref","is-referenced-by-count":4,"title":["Pregnancy and lactation after breast cancer elevate plasma prolactin, do not shorten and may prolong survival"],"prefix":"10.1016","volume":"73","author":[{"given":"Dani","family":"Bercovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2009.06.031_bib1","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2009.06.031_bib2","series-title":"Textbook of endocrinology","year":"1981"},{"key":"10.1016\/j.mehy.2009.06.031_bib3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/jnci\/90.11.814","article-title":"Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer","volume":"90","author":"Colditz","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.06.031_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-540-71274-9_6","article-title":"Subsequent pregnancy after breast cancer","volume":"178","author":"Peccatori","year":"2008","journal-title":"Recent Res Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0002-9378(94)70290-X","article-title":"Survival of breast cancer patients after subsequent term pregnancy: \u201chealthy mother effect\u201d","volume":"70","author":"Sankila","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2009.06.031_bib6","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2424::AID-CNCR17>3.0.CO;2-4","article-title":"Pregnancy after breast carcinoma: outcomes and influence on mortality","volume":"85","author":"Velentgas","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1701-2163(16)30298-5","article-title":"Breast cancer, pregnancy, and breastfeeding","volume":"24","author":"Helewa","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.mehy.2009.06.031_bib8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cncr.11634","article-title":"Childbearing and survival after breast carcinoma in young women","volume":"98","author":"Mueller","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bmj.39035.667176.55","article-title":"Pregnancy after breast cancer: population based study","volume":"334","author":"Ives","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2009.06.031_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-008-9983-7","article-title":"Breast-feeding after breast cancer: if you wish, madam","volume":"114","author":"Azim","year":"2009","journal-title":"Breast Cancer Res Tr"},{"key":"10.1016\/j.mehy.2009.06.031_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0895-4356(89)90161-3","article-title":"The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and steroid hormone study group","volume":"42","author":"Layde","year":"1989","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.bjc.6600124","article-title":"E3N-epic group. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer: results from a large cohort of French women","volume":"86","author":"Clavel-Chapelon","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1200\/JCO.2001.19.6.1671","article-title":"International breast cancer study group. Effect of pregnancy on overall survival after the diagnosis of early stage breast cancer","volume":"9","author":"Gerber","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2009.06.031_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/carcin\/20.4.623","article-title":"Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats","volume":"20","author":"Yang","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mehy.2009.06.031_bib15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnci\/92.4.302","article-title":"History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature","volume":"92","author":"Lipworth","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.06.031_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/aje\/154.1.37","article-title":"Sigurvinsson1 T. Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study","volume":"154","author":"Tryggvad\u00dbttir","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","article-title":"Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without the disease","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2009.06.031_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/BF03347114","article-title":"Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation","volume":"14","author":"Fonseca","year":"1991","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.mehy.2009.06.031_bib19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF03348932","article-title":"Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance","volume":"16","author":"Hoffmann","year":"1993","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.mehy.2009.06.031_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1026329731268","article-title":"Cleavage of prolactin by its target organs and the possible significance of this process","volume":"2","author":"Nicoll","year":"1997","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.mehy.2009.06.031_bib21","first-page":"2563","article-title":"Ontogeny and evolution of prolactin\u2019s functions","volume":"39","author":"Nicoll","year":"1980","journal-title":"Fed Proc"},{"key":"10.1016\/j.mehy.2009.06.031_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bjc.6690003","article-title":"Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer","volume":"79","author":"Lipworth","year":"1999","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib23","series-title":"Human prolactin","article-title":"Phenothiazines and breast cancer","author":"Wilson","year":"1973"},{"key":"10.1016\/j.mehy.2009.06.031_bib24","first-page":"3106","article-title":"Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women","volume":"44","author":"Ross","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/oxfordjournals.aje.a010091","article-title":"Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines","volume":"150","author":"Kelly","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/gut.33.9.1280","article-title":"Postmarketing surveillance of the safety of cimetidine: 10 year mortality report","volume":"33","author":"Colin-Jones","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.mehy.2009.06.031_bib27","first-page":"319","article-title":"Cimetidine use and risk of prostate and breast cancer","volume":"9","author":"Rossing","year":"2000","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.mehy.2009.06.031_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/1055-9965.EPI-04-0547","article-title":"Cimetidine and other histaminereceptor antagonist use in relation to risk of breast cancer","volume":"14","author":"Coogan","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.mehy.2009.06.031_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1152\/jappl.1998.84.2.703","article-title":"Effects of hormone replacement on growth hormone and prolactin exercise responses in postmenopausal women","volume":"84","author":"Kraemer","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1113\/eph8702342","article-title":"Hyperprolactinaemia during 18 prolonged exercise in the heat: evidence for a centrally mediated component of fatigue in trained cyclists","volume":"87","author":"Pitsiladis","year":"2002","journal-title":"Exp Physiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1113\/expphysiol.2004.027839","article-title":"Paroxetine administration to influence human exercise capacity, perceived effort or hormone responses during prolonged exercise in a warm environment","volume":"89","author":"Strachan","year":"2004","journal-title":"Exp Physiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jnci\/90.15.1155","article-title":"Physical activity and breast cancer risk in a cohort of young women","volume":"90","author":"Rockhill","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.06.031_bib33","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1054\/bjoc.1999.0987","article-title":"Breast cancer among former college athletes compared to non-athletes: a 15-year follow-up","volume":"82","author":"Wyshak","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1158\/1055-9965.EPI-05-0603","article-title":"Effect of physical activity on women at increased risk of breast cancer: results from the E3N cohort study","volume":"15","author":"Tehard","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.mehy.2009.06.031_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.ede.0000251167.75581.98","article-title":"Physical activity and breast cancer: a systematic review","volume":"18","author":"Monninkhof","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.mehy.2009.06.031_bib36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bjsm.2006.029132","article-title":"Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects","volume":"42","author":"Friedenreich","year":"2008","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.mehy.2009.06.031_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jnci\/91.7.629","article-title":"Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women","volume":"91","author":"Hankinson","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.06.031_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/aje\/kwh327","article-title":"Job stress and breast cancer risk: the nurses\u2019 health study","volume":"160","author":"Schernhammer","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/aje\/kwh148","article-title":"Caregiving stress, endogenous sex steroid hormone levels, and breast cancer incidence","volume":"59","author":"Kroenke","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.mehy.2007.05.027","article-title":"Prolactin does not cause breast cancer and may prevent it or be therapeutic in some conditions","volume":"70","author":"Goodman","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2009.06.031_bib41","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-04-1870","article-title":"Plasma prolactin concentrations and risk of postmenopausal breast cancer","volume":"64","author":"Tworoger","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib42","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1158\/0008-5472.CAN-05-3369","article-title":"Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women","volume":"66","author":"Tworoger","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib43","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.2006.07.6356","article-title":"A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer","volume":"25","author":"Tworoger","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2009.06.031_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2001-0036","article-title":"The role of prolactin in mammary carcinoma","volume":"24","author":"Clevenger","year":"2003","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.mehy.2009.06.031_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr921","article-title":"Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones","volume":"6","author":"Hankinson","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2006.01.032","article-title":"Prolactin and breast cancer risk","volume":"243","author":"Tworoger","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.mehy.2009.06.031_bib47","doi-asserted-by":"crossref","unstructured":"Hankinson SE. Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 2005\u20132006;24:3\u201315.","DOI":"10.3233\/BD-2006-24102"},{"key":"10.1016\/j.mehy.2009.06.031_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10911-008-9063-y","article-title":"Prolactin and breast cancer etiology: an epidemiologic perspective","volume":"13","author":"Tworoger","year":"2008","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.mehy.2009.06.031_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/978-0-387-78818-0_10","article-title":"Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies","volume":"630","author":"Eliassen","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mehy.2009.06.031_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0531-5565(99)00078-9","article-title":"Involvement of prolactin in breast cancer: redefining the molecular targets","volume":"35","author":"Llovera","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.mehy.2009.06.031_bib51","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1210\/jc.86.8.3826","article-title":"Mutational analysis of the PRL receptor gene in human breast tumors with differential PRL receptor protein expression","volume":"86","author":"Glasow","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2009.06.031_bib52","doi-asserted-by":"crossref","unstructured":"Dumitrescu RG, Cotarla I. Understanding breast cancer risk \u2013 where do we stand in 2005? J Cell Mol Med 2005;l 9:208\u201321.","DOI":"10.1111\/j.1582-4934.2005.tb00350.x"},{"key":"10.1016\/j.mehy.2009.06.031_bib53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1191\/0960327106ht643oa","article-title":"Hyperprolactinaemia as an adverse effect in 21 regulatory and clinical toxicology: role in breast and prostate cancer","volume":"25","author":"Harvey","year":"2006","journal-title":"Human Exp Toxicol"},{"key":"10.1016\/j.mehy.2009.06.031_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/foc.4.1.115","article-title":"Gender differences in the prescribing of antipsychotic drugs","volume":"4","author":"Seeman","year":"2006","journal-title":"Focus"},{"key":"10.1016\/j.mehy.2009.06.031_bib55","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/jc.2005-1899","article-title":"Association of prolactin and its receptor gene regions with familial breast cancer","volume":"91","author":"Vaclavicek","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2009.06.031_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2350-8-72","article-title":"A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort","volume":"8","author":"Lee","year":"2007","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.mehy.2009.06.031_bib57","doi-asserted-by":"crossref","unstructured":"Perotti C, Liu R, Parusel CT, et al. Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation. Biomed Central 2008;10 (No 6 research article).","DOI":"10.1186\/bcr2193"},{"key":"10.1016\/j.mehy.2009.06.031_bib58","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/0008-5472.CAN-08-4033","article-title":"Impaired turnover of prolactin receptor contributes to transformation of human breast cells","volume":"69","author":"Plotnikov","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0277-5379(86)90116-1","article-title":"Serum prolactin levels in women with breast cancer and their relationship to survival","volume":"22","author":"Wang","year":"1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.mehy.2009.06.031_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.epirev.a036116","article-title":"Endogenous hormones and breast cancer risk","volume":"15","author":"Bernstein","year":"1993","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.mehy.2009.06.031_bib61","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0277-5379(87)90098-8","article-title":"The relation between blood prolactin levels and risk of breast cancer in premenopausal women","volume":"10","author":"Wang","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.mehy.2009.06.031_bib62","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ije\/21.2.214","article-title":"Relationship of blood prolactin levels and the risk of subsequent breast cancer","volume":"21","author":"Wang","year":"1992","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib63","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000066228","article-title":"Postoperative hyperprolactinemia could predict longer disease-free and overall survival in node-negative breast cancer patients","volume":"63","author":"Mandala","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.mehy.2009.06.031_bib64","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ijc.2910280603","article-title":"A pros pective study of plasma prolactin levels and subsequent risk of breast cancer","volume":"28","author":"Kwa","year":"1981","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib65","first-page":"1347","article-title":"Malignant breast tumours amongst atomic bomb survivors","volume":"62","author":"Tokunago","year":"1979","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2009.06.031_bib66","first-page":"575","article-title":"A prospective study of estradiol and breast cancer in Japanese women","volume":"9","author":"Kabuto","year":"2000","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.mehy.2009.06.031_bib67","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1025671317220","article-title":"Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)","volume":"14","author":"Manjer","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.mehy.2009.06.031_bib68","doi-asserted-by":"crossref","unstructured":"Anders CA, Acharya CR, Hsu DS, et al. Age-specific differences in oncogenic pathway deregulation seen in human breast tumours. PlosONE 2008;3:1\u20137 (e1373).","DOI":"10.1371\/journal.pone.0001373"},{"key":"10.1016\/j.mehy.2009.06.031_bib69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2964(79)90037-9","article-title":"Prolactin and human breast cancer: a review","volume":"15","author":"Nagasawa","year":"1979","journal-title":"Europ J Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1026325630359","article-title":"Prolactin as an autocrine\/paracrine factor in breast tissue","volume":"2","author":"Clevenger","year":"1997","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.mehy.2009.06.031_bib71","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1677\/erc.0.0060389","article-title":"Prolactin involvement in breast cancer","volume":"6","author":"Vonderhaar","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1677\/joe.1.06829","article-title":"Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma","volume":"190","author":"Manhes","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.mehy.2009.06.031_bib73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcp.1041320123","article-title":"Influence of hormone and growth factor interactions on the proliferative potential of normal rat mammary epithelial cells in vitro","volume":"132","author":"Ethier","year":"1987","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.mehy.2009.06.031_bib74","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/excr.1994.1015","article-title":"Control of mammary epithelial cell DNA synthesis by epidermal growth factor, cholera toxin, and IGF-1: specific inhibitory effect of prolactin on EGF-stimulated cell growth","volume":"210","author":"Fenton","year":"1994","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib75","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/0008-5472.CAN-05-2292","article-title":"Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells","volume":"66","author":"Nouhi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib76","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/sj.onc.1208203","article-title":"Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells","volume":"24","author":"Sultan","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.mehy.2009.06.031_bib77","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrc1209","article-title":"AP-1: a double-edged sword in tumorigenesis","volume":"3","author":"Eferl","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib78","first-page":"594","article-title":"Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis","volume":"9","author":"Dolled-Filhard","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib79","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1200\/JCO.2004.11.046","article-title":"Signal transducer and activator of transcription-5 activation and breast cancer prognosis","volume":"22","author":"Nevalainen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2009.06.031_bib80","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1210\/en.133.3.1292","article-title":"The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis","volume":"133","author":"Clapp","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2009.06.031_bib81","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1158\/0008-5472.CAN-07-0986","article-title":"16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2009.06.031_bib82","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1073\/pnas.96.4.1246","article-title":"Opposing actions of intact and N-terminal fragments of the human prolactin\/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis","volume":"96","author":"Struman","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2009.06.031_bib83","unstructured":"Scotti ML, Peirce SK, Tomblyn S, et al. Co-expression of human prolactin drastically reduces breast cancer incidence in HER2\/neu transgenic mice. Proc Amer Assoc Cancer Res 2006;47 (abstract #695)."},{"key":"10.1016\/j.mehy.2009.06.031_bib84","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/bjc.1990.346","article-title":"Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study","volume":"62","author":"De Placido","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2009.06.031_bib85","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/carcin\/23.7.1095","article-title":"The initiation of breast and prostate cancer","volume":"23","author":"Grover","year":"2002","journal-title":"Carcinogenesis"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709004642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709004642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T17:57:59Z","timestamp":1558461479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709004642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0306987709004642"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.06.031","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}